IRIS
MADEDDU, Denise
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.727
EU - Europa 1.979
AS - Asia 1.918
SA - Sud America 276
AF - Africa 79
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 6.984
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.659
CN - Cina 721
SG - Singapore 706
IT - Italia 445
SE - Svezia 355
IE - Irlanda 346
BR - Brasile 228
FI - Finlandia 213
DE - Germania 211
HK - Hong Kong 166
VN - Vietnam 104
TR - Turchia 73
FR - Francia 64
NL - Olanda 61
ZA - Sudafrica 59
GB - Regno Unito 55
AT - Austria 50
CA - Canada 44
IN - India 44
UA - Ucraina 39
BE - Belgio 38
BD - Bangladesh 27
CZ - Repubblica Ceca 26
RU - Federazione Russa 19
PL - Polonia 18
MX - Messico 16
AR - Argentina 15
IQ - Iraq 13
JP - Giappone 13
LT - Lituania 13
EC - Ecuador 12
CI - Costa d'Avorio 9
ID - Indonesia 8
PK - Pakistan 8
UZ - Uzbekistan 8
CO - Colombia 6
ES - Italia 6
MA - Marocco 6
RO - Romania 6
JO - Giordania 5
VE - Venezuela 5
AZ - Azerbaigian 4
CH - Svizzera 4
OM - Oman 3
UY - Uruguay 3
AU - Australia 2
BO - Bolivia 2
EU - Europa 2
HN - Honduras 2
IL - Israele 2
IR - Iran 2
KE - Kenya 2
PE - Perù 2
PY - Paraguay 2
RS - Serbia 2
SA - Arabia Saudita 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BB - Barbados 1
BG - Bulgaria 1
BT - Bhutan 1
BY - Bielorussia 1
BZ - Belize 1
CL - Cile 1
EG - Egitto 1
HU - Ungheria 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MK - Macedonia 1
MT - Malta 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.984
Salva come PNG Salva come JPEG
Città #
Chandler 391
Singapore 371
Dublin 346
Ashburn 333
Dallas 206
Ann Arbor 186
Parma 174
Hong Kong 163
Beijing 159
Santa Clara 159
Dearborn 112
Boardman 107
New York 87
Shanghai 78
Munich 76
Nanjing 76
Izmir 57
Johannesburg 57
Padova 57
Los Angeles 56
Princeton 54
Bremen 48
Wilmington 45
Jacksonville 43
Vienna 43
Helsinki 41
Brussels 38
Ho Chi Minh City 37
Nanchang 31
Jinan 28
Buffalo 25
Hebei 24
Hanoi 22
São Paulo 22
Columbus 21
Seattle 21
San Mateo 18
Brooklyn 17
Pune 17
Shenyang 17
Des Moines 16
Guangzhou 16
Hefei 16
Jiaxing 16
Kunming 16
Rio Saliceto 16
Toronto 16
Turku 16
London 15
Warsaw 14
Changsha 13
Milan 13
Norwalk 13
Brno 12
Fremont 12
Moscow 12
Zhengzhou 12
Frankfurt am Main 11
The Dalles 11
Denver 10
Houston 10
Nuremberg 10
Redmond 10
Tianjin 10
Tokyo 10
Tulsa 10
Abidjan 9
Hangzhou 9
Woodbridge 9
Chennai 8
Haiphong 8
Modena 8
Montreal 8
Olomouc 8
Rio de Janeiro 8
Stockholm 8
Boston 7
Falkenstein 7
Falls Church 6
Guayaquil 6
Haikou 6
Jakarta 6
Kocaeli 6
Marseille 6
Phoenix 6
Redwood City 6
Amman 5
Amsterdam 5
Atlanta 5
Campinas 5
Contagem 5
Council Bluffs 5
Curitiba 5
Genova 5
Mexico City 5
Ottawa 5
Redondo Beach 5
Rome 5
Secaucus 5
Sector 6 5
Totale 4.414
Salva come PNG Salva come JPEG
Nome #
Parenchymal and Stromal Cells Contribute to Pro-Inflammatory Myocardial Environment at Early Stages of Diabetes: Protective Role of Resveratrol 234
Cardioprotection by Targeting the Pool of Resident and Extracardiac Progenitors 182
Validation of a radiomic approach to decipher NSCLC immune microenvironment in surgically resected patients 180
L’autofagia coinvolge i cardiomiociti e le cellule progenitrici nella cardiomiopatia indotta da imatinib mesilato 179
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC 169
MESENCHYMAL STROMAL CELLS ISOLATED FROM DEFINED NSCLC CONTEXTURES REPRODUCE THE IMMUNE SIGNATURE OF THE PARENTAL MICROENVIRONMENT 165
Enhancement of the anti-tumor activity of FGFR1 inhibition in squamous cell lung cancer by targeting downstream signaling involved in glucose metabolism. 162
Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells. 162
Lymphangiogenesis in genetically determined hypertrophic obstructive cardiomyopathy 160
The circulating pool of functionally competent NK and CD8+ cells predicts the outcome of anti-PD1 treatment in advanced NSCLC 157
Imatinib mesylate-induced cardiomyopathy involves resident cardiac progenitors 156
Combination of Gefitinib and Pemetrexed Prevents the Acquisition of TKI Resistance in NSCLC Cell Lines Carrying EGFR-Activating Mutation 154
Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring PIK3CA Gene Alterations. 150
Low PD-1 expression in Cytotoxic CD8+ Tumor infiltrating Lymphocytes Confers an Immune Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value 150
INTEGRATION OF TISSUE PD-1/PD-L1 IMMUNE CHECKPOINT WITH COMPUTED TOMOGRAPHY (CT) BASED TEXTURE ANALYSIS EXHIBITS HIGH PROGNOSTIC IMPACE ON SURGICALLY RESECTED NON SMALL CELL LUNG CANCER (NSCLC) 148
Blood and lymphatic vessels contribute to the impact of the immune microenvironment on clinical outcome in non-small-cell lung cancer 145
Bone Marrow Remodelling and Topographic Redistribution of CD34 Positive Progenitors Characterize the Progression of Myelodysplastic Syndromes and Their Evolution to AML 145
Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines 143
Cancer treatment-induced cardiotoxicity: a cardiac stem cell disease? 139
BLOOD AND LYMPHATIC VESSELS CONSTITUTE AN ESSENTIAL COMPONENT OF THE IMMUNE MICROENVIRONMENT AND ITS IMPACT ON NON SMALL CELL LUNG CANCER (NSCLC) CLINICAL OUTCOME 137
In Vitro Biological and Functional Properties of Human Endothelial Cells from Different Sources Exposed to Different Beta-Blockers 137
Potential involvement of cardiac and bone marrow vascular progenitors in imatinib induced cardiovascular toxicity 135
Assessment of Cardiac Patches Suitability for Tissue Engineering 135
Enhanced efficacy of AKT and FAK kinase combined inhibition in squamous cell lung carcinomas with stable reduction in PTEN 135
Isolation and characterization of human lung lymphatic endothelial cells 133
Dissecting the cellular mechanisms of cardiotoxicity by anthracycline and tyrosine kinase inhibitors 130
Lung mesenchymal cells function as an inductive microenvironment for human lung cancer propagating cells† 129
Clinico-Immunological Profile of a 67-Year-Old Woman Affected by HER2-Positive Breast Cancer and Autoimmune Dermatomyositis 129
Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer 129
Identification and tumorigenic role of Mesenchymal Stem Cells from human lung cancer 127
Resident cardiac stem cells. 125
Spatial architecture of tumour-infiltrating lymphocytes as a prognostic parameter in resected non-small-cell lung cancer 124
Stem cells and myocardial regeneration 124
Notch Activation Modulates Bevacizumab Activity by CD44 Positive Cancer Stem Cells in Advanced Colon Cancer 123
Tyrosine kinase cardiotoxicity: ultrastructural analysis of imatinib mesylate induced cardiomyopathy 117
Structural and Functional Characterization of the Hemolymphangiogenic Microenvironment in Lung Cancer 117
Integrated CT imaging and tissue immune features disclose a radio-immune signature with high prognostic impact on surgically resected NSCLC 115
SURGICAL SAMPLING IS AN EMERGING ISSUE IN THE ASSESSMENT OF THE IMMUNE CONTEXTURE IN NON SMALL CELL LUNG CANCER (NSCLC) 110
Differential Pattern of Myocardial Remodelling in Genetically Determined and Load- Dependent Hypertrophy in Humans 109
YES1 and MYC Amplifications as Synergistic Resistance Mechanisms to Different Generation ALK Tyrosine Kinase Inhibitors in Advanced NSCLC: Brief Report of Clinical and Preclinical Proofs 106
Development of biomimetic alginate/gelatin/elastin sponges with recognition properties toward bioactive peptides for cardiac tissue engineering 105
IMPACT OF THE TISSUE DISTRIBUTION OF SUBPOPULATIONS OF TILS AND PD-L1 EXPRESSION ON THE CLINICAL OUTCOME OF NSCLC 104
Biomimetic poly(glycerol sebacate) (PGS) membranes for cardiac patch application 98
Favorable clinical outcome and response to immunotherapy share a common PD-L1/PD-1 based NSCLC immune contexture 97
LUNG MESENCHYMAL STEM CELLS FUNCTION AS THE INDUCTIVE MICROENVIRONMENT FOR HUMAN LUNG CANCER PROPAGATING CELLS 97
Differential Tumorigenic Properties of Mesenchymal Cells From Neoplastic and Non-Neoplastic Human Lung in NSCLC 96
IGF-1 loaded injectable microspheres for potential repair of the infarcted myocardium 96
Correction: A versatile bioreactor for dynamic suspension cell culture. Application to the culture of cancer cell spheroids 90
Low vagally-mediated heart rate variability and increased susceptibility to ventricular arrhythmias in rats bred for high anxiety. 88
Influence of injectable microparticle size on cardiac progenitor cell response 86
Inhibition of Human Malignant Pleural Mesothelioma Growth by Mesenchymal Stromal Cells 84
Advanced CT imaging features reflect distinct tissue immune profiles and exhibit high prognostic impact on NSCLC 81
Divergent PD-1 expression in tissue and circulating CD8 lymphocytes defines an immune profile predictive of the response to nivolumab in advanced NSCLC 75
Reinforced alginate/gelatin sponges functionalized by avidin/biotin-binding strategy: a novel cardiac patch 75
In vitro suspension bioreactor-based platform for culturing tumor cell clusters 72
Thermoreversible injectable polyurethane hydrogels: future challenges for biomedical applications 62
Totale 7.112
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.422
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.422
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021230 0 0 0 0 0 29 21 31 51 25 55 18
2021/2022273 17 11 9 14 4 10 39 21 12 21 11 104
2022/20231.486 150 184 95 120 158 154 35 81 420 8 67 14
2023/2024554 21 39 8 16 49 148 51 23 16 46 66 71
2024/20251.390 27 70 101 113 158 122 80 70 128 120 138 263
2025/20261.665 331 254 356 284 430 10 0 0 0 0 0 0
Totale 7.112